Induction of the arginine vasopressin-enhanced green fluorescent protein fusion transgene in the rat locus coeruleus

Stress

Volumn 13, Issue 4, 2010, Pages 281-292

  Todoroki, Miwako ^a   Ueta, Yoichi ^a   Fujihara, Hiroaki ^a   Otsubo, Hiroki ^a   Shibata, Minori ^a   Hashimoto, Hirofumi ^a   Kobayashi, Mizuki ^a   Sakamoto, Hirotaka ^b   Kawata, Mitsuhiro ^b   Dayanithi, Govindan ^c   Murphy, David ^d   Hiro, Hisanori ^a   Takahashi, Ken ^a   Nagata, Shoji ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Colchicine; Green fluorescent protein; Hypothalamus; Locus coeruleus; Noradrenaline; Stress; Vasopressin

Indexed keywords

ARGIPRESSIN; COLCHICINE; ENHANCED GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; MESSENGER RNA; NORADRENALIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; IMMOBILIZATION STRESS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; LOCUS CERULEUS; MAGNOCELLULAR NUCLEUS; MEDIAN EMINENCE; NEUROHYPOPHYSIS; NOCICEPTIVE STIMULATION; NONHUMAN; NORADRENERGIC NERVE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SLEEP DEPRIVATION; STRESS; SUPRACHIASMATIC NUCLEUS; SUPRAOPTIC NUCLEUS; TRANSGENE; UPREGULATION;

EID: 77953472925     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.3109/10253890903383406     Document Type: Article

References (33)

1. Aguilera G, Rabadan-Diehl C. 2000. Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: Implications for stress adaptation. Regul Pept 96:23-29.
2. Amaral DG, Sinnamon HM. 1977. The locus coeruleus: Neurobiology of a central noradrenergic nucleus. Prog Neuro-biol 9:147-196.
3. Berod A, Chat M, Paut L, Tappaz M. 1984. Catecholaminergic and GABAergic anatomical relationship in the rat substantia nigra, locus coeruleus, and hypothalamic median eminence. J Histochem Cytochem 32:1331-1338.
4. Berrigde CW. 2008. Noradrenergic modulation of arousal. Brain Res Rev 58:1-17.
5. Bouret S, Sara SJ. 2005. Network reset: A simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci 28:574-582.
6. Caffe AR, van Leeuwen FW, Buijs RM, de Vries GJ, Geffard M. 1985. Coexistence of vasopressin, neurophysin and noradrena-line immunoreactivity in medium-sized cells of the locus coeruleus and subcoeruleus in the rat. Brain Res 338:160-164.
7. Chan-Palay V, Jonsson G, Palay SL. 1978. Serotonin and substance P coexist in neurons of the rat's central nervous system. Proc Natl Acad Sci USA 75:1582-1586.
8. Charnay Y, Leger L, Dray F, Berod A, Jouvet M, Pujol JF, Dubois PM. 1982. Evidence for the presence of enkephalin in catecholaminergic neurons of cat locus coeruleus. Neurosci Lett 30:147-151.
9. Dahlstrom A, Fuxe K. 1964. Evidence for the existence of monoamine-containing neurons in the central nervous system. Acta Physiol Scand 232:1-55.
10. de Vries GJ, Miller MA. 1998. Anatomy and function of extrahypothalamic vasopressin systems in the brain. Prog Brain Res 119:3-20.
11. Dluzen DE, Muraoka S, Landgraf R. 1998. Olfactory bulb norepinephrine depletion abolishes vasopressin and oxytocin preservation of social recognition responses in rats. Neurosci Lett 254:161-164.
12. Emerich DF, Walsh TJ. 1990. Cholinergic cell loss and cognitive impairments following intraventricular or intradentate injection of colchicine. Brain Res 517:157-167.
13. Everitt BJ, Hökfelt T, Terenius L, Tatemoto K, Mutt V, Goldstein M. 1984. Differential co-existence of neuropeptide Y (NPY)-like immunoreactivity with catecholamines in the central nervous system of the rat. Neuroscience 11:443-462. (Pubitemid 14155718)
14. Fujio T, Fujihara H, Shibata M, Yamada S, Onaka T, Tanaka K, Morita H, Dayanithi G, Kawata M, Murphy D, Ueta Y. 2006. Exaggerated response of arginine vasopressin-enhanced green fluorescent protein fusion gene to salt loading without disturbance of body fluid homeostasis in rats. J Neuroendocrinol 18:776-785.
15. Giri PR, Dave JR, Tabakoff B, Hoffman PL. 1990. Arginine vasopressin induces the expression of c-fos in the mouse septum and hippocampus. Brain Res Mol Brain Res 7:131-137. (Pubitemid 20039552)
16. Goebel M, Stengel A, Wang L, Taché Y. 2009. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res 1300:114-124.
17. Hannibal J, Mikkelsen JD, Fahrenkrug J, Larsen PJ. 1995. Pituitary adenylate cyclase-activating peptide gene expression in cortico-tropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, either, or restraint stress. Endocrinol 136:4116-4124.
18. Iijima K. 1989. An immunocytochemical study on the GABA-ergic and serotonin-ergic neurons in rat locus coeruleus with special reference to possible existence of the masked indoleamine cells. Acta Histochem 87:43-57.
19. Iijima K, Ohmoto K. 1988. Immunocytochemical study using a GABA antiserum for the demonstration of inhibitory neurons in the rat locus coeruleus. Am J Anat 181:43-52.
20. Iijima K, Sato M. 1991. An immnocytochemical study using the PAP method for tyrosine hydroxylase and serotonin in alternate sections, and in situ hybridisation to detect tryptophan hydroxylase mRNA in the rat's locus coeruleus. Acta Histochem 90:159-172.
21. Johansson O, Hökfelt T, Elde RP. 1984. Immunohistochemical distribution of somatostatin-like immunoreactivity in the central nervous system of the adult rat. Neuroscience 13:265-339. (Pubitemid 15211943)
22. Jones SL. 1991. Descending noradrenergic influence on pain. Prog Brain Res 88:381-394.
23. Kalia M, Fuxe K, Goldstein M. 1985. Rat medulla oblongata? Dopaminergic, noradrenergic (A1 and A2) and adrenergic neurons, nerve fibers, and presumptive terminal process. J Comp Neuro 233:308-332. (Pubitemid 15132720)
24. Levy A, Lightman SL, Carter DA, Murphy D. 1990. The origin and regulation of posterior pituitary vasopressin ribonucleic acid in osmotically stimulated rats. J Neuroendocrinol 2:329-334.
25. LevyF, Kendrick KM, Goode JA, Guevara-Guzman R, Keverne EB. 1995. Oxytocin and vasopressin release in the olfactory bulb of parturient ewes: Changes with maternal experience and effects on acetylcholine, gamma-aminobutyric acid, glutamate and noradrenaline release. Brain Res 669:197-206.
26. Paxinos G, Watson C. 1986. The Rat Brain in Stereotoxic Coordinates. Sydney: Sydney Academic Press.
27. Roozendaal B, Schoorlemmer GH, Koolhaas JM, Bohus B. 1993. Cardiac, neuroendocrine, and behavioral effects of central amygdaloid vasopressinergic and oxytocinergic mechanisms under stress-free conditons in rats. Brain Res Bull 32:573-579.
28. Shibata M, Fujihara H, Suzuki H, Ozawa H, Kawata M, Dayanithi G, Murphy D, Ueta Y. 2007. Physiological studies of stress responses in the hypothalamus of vasopressin-enhanced green fluorescent protein transgenic rat. J Neuroendocrinol 19: 285-292.
29. Sofroniew MV, Weindl A. 1980. Identification of parvocellular vasopressin and neurophysin neurons in the suprachiasmatic nucleus of a variety of mammals including primates. J Comp Neurol 193:659-675.
30. Steindler DA, Trosko BK. 1989. Two types of locus coeruleus neurons born on different embryonic days in the mouse. Anat Embryol 179:423-434.
31. Ueta Y, Fujihara H, Serino R, Dayanithi G, Ozawa H, Matsuda K, Kawata M, Yamada J, Ueno S, Fukuda A, Murphy D. 2005. Transgenic expression of enhanced green fluorescent protein enables direct visualization for physiological studies of vaso-pressin neurons and isolated nerve terminals of the rat. Endocrinol 146:406-413.
32. Westfall TC, Westfall DP. 2006. Neurotransmission: The automatic and somatic motor nervous systems. In: Brunton LL, Laoz JS, Parker DP, editors. Goodman & Gilman's the pharmacological basis of therapeutics. 11th ed. New York, NY: McGraw-Hill. p 137-182.
33. Zhang BJ, Kusano K, Zerfas P, Iacangelo A, Young WS, 3rd, Gainer H. 2002. Targeting of green fluorescent protein to secretory granules in oxytocin magnocellular neurons and its secretion from neurohypophysial nerve terminals in transgenic mice. Endocrinol 143:1036-1046.